Incyte (INCY) Q2 Revenue Tops Views
Incyte (NASDAQ: INCY) reported Q2 EPS of $0.26, $0.09 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $521.52 million versus the consensus estimate of $473.78 million.
2018 Financial Guidance
The Company has updated its full year 2018 financial guidance, as detailed below.
| Current | Previous | |||||||
| GAAP and Non-GAAP Jakafi net product revenues | $1,350 - $1,400 million | Unchanged | ||||||
| GAAP and Non-GAAP Iclusig net product revenues | $80 - $85 million | Unchanged | ||||||
| GAAP Cost of product revenues | $85 - $95 million | Unchanged | ||||||
| Non-GAAP Cost of product revenues(1) | $64 - $74 million | Unchanged | ||||||
| GAAP Research and development expenses | $1,150 - $1,250 million | Unchanged | ||||||
| Non-GAAP Research and development expenses(2) | $1,008 - $1,103 million | $1,013 - $1,108 million | ||||||
| GAAP Selling, general and administrative expenses | $390 - $410 million | Unchanged | ||||||
| Non-GAAP Selling, general and administrative expenses(3) | $340 - $355 million | Unchanged | ||||||
| GAAP Change in fair value of acquisition-related contingent consideration | $30 million | Unchanged | ||||||
| Non-GAAP Change in fair value of acquisition-related contingent consideration(4) | $0 million | Unchanged |
For earnings history and earnings-related data on Incyte (INCY) click here.